Medtronic implanted drug pump gets a second class I recall

August 30, 2011 by MassDevice staff

Medtronic's SynchroMed II implantable painkiller pump undergoes its second class 1 recall this year over reports of defective batteries.

SynchroMed II pain pump

Medtronic Inc.'s (NYSE:MDT) urgent update last month turned into a second class I recall for its SynchroMed II implantable drug infusion pumps over reports that the devices may have defective batteries that can lead to sudden failure.

The SynchroMed system includes an implanted catheter and pump infusion system that stores and delivers medication to a specific site. There are about 140,000 pumps in use worldwide.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp